在瘤学中,放射性体和治疗学方面的进步
Ismaheel O Lawal1,2, Sofiullah O Abubakar3, Honest Ndlovu4,5
1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, NE, Atlanta, GA, 30322, USA. ilawal@emory.edu.
Molecular diagnosis & therapy
|March 31, 2024
概括
放射性疗法使用放射性子进行精确的癌症成像和治疗,个性化患者护理. 像177Lu-DOTATATE和177Lu-PSMA这样的经批准的药物可以提高生存率,推动新药的开发.
科学领域:
- 在瘤学瘤学.
- 核医学就是核医学.
- 放射性药物疗法是一种放射性药物疗法.
背景情况:
- 放射性疗法利用瘤细胞上的分子标进行联合成像和治疗.
- 这种方法可以在治疗干预之前对目标表达进行非侵入性评估.
- 在瘤学中,个性化医疗是通过确保只有可能响应的人才接受治疗而取得的进步.
研究的目的:
- 审查最近在既定和新兴的放射性耐热剂方面的进展.
- 讨论放射性瘤学中放射性瘤学的临床转化.
- 提供关于放射性应用的文献的最新评估.
主要方法:
- 关于已确定的放射性射剂的文献综述.
- 对最近批准的药物如177Lu-DOTATATE和177Lu-PSMA进行分析.
- 对新型标 (FAP,CXCR4,PARP,EGFR2) 的临床前和早期临床数据的讨论.
主要成果:
- 确定的药物 (放射性,131I-mIBG) 对于特定的癌症仍然至关重要.
- 177Lu-DOTATATE和177Lu-PSMA已经证明了生存益处和监管批准.
- 针对FAP,CXCR4,PARP和EGFR2的新兴药物在临床前和早期临床研究中显示出有前途.
结论:
- 放射性治疗是瘤学中快速发展的领域,具有显著的临床影响.
- 经批准的药物改变了神经内分泌瘤和前列腺癌的治疗方法.
- 正在进行的对新型放射性射目标的研究为未来的癌症疗法提供了潜力.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
112
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
112
Positron Emission Tomography
4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K


